Beginning in April 2023, there have been reports of Syfovre eye injury cases, including retinal vasculitis resulting in significant vision loss. As of the beginning of April 2024, however, retina specialists seem to agree that both the etiology and the incidence rate of retinal vasculitis after Syfovre injections remain uncertain.
Put in more simple terms, the cause is still unknown and the number of patients remains unclear when it comes to retinal vasculitis after Syfovre injections.
There are at least two difficulties when determining the number of Syfovre eye injury cases involving retinal vasculitis that have occurred to date:
- It is generally acknowledged that voluntary reporting of prescription drug adverse events is inherently subject to underreporting. Therefore, it is likely that some Syfovre retinal vasculitis cases have not been reported to the FDA, Apellis Pharmaceuticals, or retina specialists; and,
- Some Syfovre patients who developed “mild” retinal vasculitis might not have been identified because they did not receive a careful dilated fundus examination or fluorescein angiography (FA). As such, these patients who might have developed retinal vasculitis are not counted by the Syfovre injections incidence rate.
We are investigating Syfovre eye injury cases for patients who suffered vision loss due to retinal vasculitis after Syfovre injections. These Syfovre lawsuits would be filed against Apellis Pharmaceuticals, not the patients’ ophthalmologists or retina specialists.
We have been monitoring this Syfovre drug safety issue and continue to report significant developments on our Drug Injury Watch website. We list our three most recent articles if you want to learn more:
- Syfovre Case Report: Occlusive Retinal Vasculitis Shortly After Patient’s First Syfovre Injection (3/6/2024)
- Syfovre Safety Issues Need More Attention Before This Relatively New Eye Drug Gets Widely Prescribed (12/27/2023)
- Syfovre Update: New Warnings About Retinal Vasculitis and/or Retinal Vascular Occlusion After Syfovre Injections (12/4/2023)
If we can assist you or someone you know, our Syfovre Case Evaluation Form is available online, or you can call us at (800) 426-9535 to speak about a possible Syfovre eye injury case.
[Read article in full at original source]Syfovre
Free Case Evaluation
Strictly Confidential, No Obligation